Test Strip Access Act of 2023

Bill: 118-hr-4106
Sponsor: full_name: Rep. Crockett, Jasmine [D-TX-30]
Introduced: 2023-06-14
Policy area: Health
Subjects: Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health programs administration and funding

Health promotion and preventive care

Mental health
Latest action: action_date: 2023-06-16
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-06-14
action_desc: Introduced in House
text: <p><strong>Test Strip Access Act of 2023&nbsp;</strong></p><p>This bill specifically allows state and tribal opioid response grants, which are administered by the Substance Abuse and Mental Health Services Administration, to be used for fentanyl or xylazine test strips.</p><!--tinycomments|2.1|data:application/json;base64,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-->

tv_txt: I 118th CONGRESS 1st Session H. R. 4106 IN THE HOUSE OF REPRESENTATIVES June 14, 2023 Ms. Crockett (for herself and Mr. Gooden of Texas ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips.

1. Short title This Act may be cited as the Test Strip Access Act of 2023 . 2. Grant program for State and Tribal response to opioid use disorders Section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee–3a(b)(4)(A)) is amended after which may include drugs or devices approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act by inserting or fentanyl or xylazine test strips .